Differential effect of platelet activating factor on 1-methyl-4-phenylpyridinium-induced cell death through regulation of apoptosis-related protein activation

Neurochemistry International

Volumn 56, Issue 6-7, 2010, Pages 819-828

  Ha, Sang Won ^a   Lee, Chung Soo ^a  

^a Chung Ang University   (South Korea)

Author keywords

1 Methyl 4 phenylpyridinium; Apoptosis related protein activation; Differential effect; PC12 cells; Platelet activating factor

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CASPASE 3; CYTOCHROME C; GLUTATHIONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; REACTIVE OXYGEN METABOLITE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; REGULATORY MECHANISM;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CASPASE 3; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLUTATHIONE; MEMBRANE POTENTIAL, MITOCHONDRIAL; PC12 CELLS; PLATELET ACTIVATING FACTOR; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; REACTIVE OXYGEN SPECIES;

PARKINSONIA;

EID: 77952288389     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.03.006     Document Type: Article

References (53)

1. Aihara M., Ishii S., Kume K., Shimizu T. Interaction between neurone and microglia mediated by platelet-activating factor. Genes Cells 2000, 5:397-406.
2. Bate C., Salmona M., Williams A. The role of platelet activating factor in prion and amyloid-β neurotoxicity. Neuroreport 2004, 15:509-513.
3. Bazan N.G., Tu B., Rodriguez de Turco E.B. What synaptic lipid signaling tells us about seizure-induced damage and epileptogenesis. Prog. Brain Res. 2002, 135:175-185.
4. Bennett S.A., Chen J., Pappas B.A., Roberts D.C., Tenniswood M. Platelet activating factor receptor expression is associated with neuronal apoptosis in an in vivo model of excitotoxicity. Cell Death Differ. 1998, 5:867-875.
5. Berthier A., Lemaire-Ewing S., Prunet C., Monier S., Athias A., Bessede G., Pais de Barros J.P., Laubriet A., Gambert P., Lizard G., Neel D. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ. 2004, 11:897-905.
6. Brewer C., Bonin F., Bullock P., Nault M.C., Morin J., Imbeault S., Shen T.Y., Franks D.J., Bennett S.A. Platelet activating factor-induced apoptosis is inhibited by ectopic expression of the platelet activating factor G-protein coupled receptor. J. Neurochem. 2002, 82:1502-1511.
7. Camins A., Pallas M., Silvestre J.S. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find. Exp. Clin. Pharmacol. 2008, 30:43-65.
8. Carlson N.G., Bacchi A., Rogers S.W., Gahring L.C. Nicotine blocks TNF-α-mediated neuroprotection to NMDA by an α-bungarotoxin-sensitive pathway. J. Neurobiol. 1998, 35:29-36.
9. + opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim. Biophys. Acta 1999, 1453:49-62.
10. +. Brain Res. Mol. Brain Res. 2003, 119:50-61.
11. Constantini P.C., Chernyak B.C., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 1996, 271:6746-6751.
12. Das K.P., Freudenrich T.M., Mundy W.R. Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol. Teratol. 2004, 26:397-406.
13. 2 activity: their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol. Rev. 2006, 58:591-620.
14. Fu W., Luo H., Parthasarathy S., Mattson M.P. Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol. Dis. 1998, 5:229-243.
15. Gahring L.C., Meyer E.L., Rogers S.W. Nicotine-induced neuroprotection against N-methyl-d-aspartic acid or β-amyloid peptide occur through independent mechanisms distinguished by pro-inflammatory cytokines. J. Neurochem. 2003, 87:1125-1136.
16. Gennero I., Fauvel J., Nieto M., Cariven C., Gaits F., Briand-Mésange F., Chap H., Salles J.P. Apoptotic effect of sphingosine 1-phosphate and increased sphingosine 1-phosphate hydrolysis on mesangial cells cultured at low cell density. J. Biol. Chem. 2002, 277:12724-12734.
17. Greene L.A., Tischler A.S. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. U.S.A. 1976, 73:2424-2428.
18. Hall A.G. The role of glutathione in the regulation of apoptosis. Eur. J. Clin. Invest. 1999, 29:238-245.
19. Hirashima Y., Ueno H., Karasawa K., Yokoyama K., Setaka M., Takaku A. Transfection of the plasma-type platelet-activating factor acetylhydrolase gene attenuates glutamate-induced apoptosis in cultured rat cortical neurons. Brain Res. 2000, 885:128-132.
20. Jin Z., El-Deiry W.S. Overview of cell death signaling pathways. Cancer Biol. Ther. 2005, 4:139-163.
21. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 2003, 53(Suppl. 3):S26-S38.
22. Kothny-Wilkes G., Kulms D., Luger T.A., Kubin M., Schwarz T. Interleukin-1 protects transformed keratinocytes from tumor-necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis. J. Biol. Chem. 1999, 274:28916-28921.
23. Langston J.W., Ballard P., Tetrud J.W., Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219:979-980.
24. ATP channel block. J. Neural. Transm. 2007, 114:297-305.
25. +-induced mitochondrial damage and cell death by trifluoperazine and W-7 in PC12 cells. Neurochem. Int. 2005, 46:169-178.
26. Lindenboim L., Yuan J., Stein R. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells. Oncogene 2000, 19:1783-1793.
27. Lipman T., Tabakman R., Lazarovici P. Neuroprotective effects of the stable nitroxide compound Tempol on 1-methyl-4-phenylpyridinium ion-induced neurotoxicity in the Nerve Growth Factor-differentiated model of pheochromocytoma PC12 cells. Eur. J. Pharmacol. 2006, 549:50-57.
28. Luberto C., Hannun Y.A. Use of short-chain ceramides. Methods Enzymol. 2000, 312:407-420.
29. Maclennan K.M., Smith P.F., Darlington C.L. Platelet-activating factor in the CNS. Prog. Neurobiol. 1996, 50:585-596.
30. Madesh M., Zong W.X., Hawkins B.J., Ramasamy S., Venkatachalam T., Mukhopadhyay P., Doonan P.J., Irrinki K.M., Rajesh M., Pacher P., Thompson C.B. Execution of superoxide-induced cell death by the proapoptotic Bcl-2-related proteins Bid and Bak. Mol. Cell. Biol. 2009, 29:3099-3112.
31. Mathieu C., Jozan S., Mazars P., Côme M.G., Moisand A., Valette A. Density-dependent induction of apoptosis by transforming growth factor-β1 in a human ovarian carcinoma cell line. Exp. Cell Res. 1995, 216:13-20.
32. Mignotte B., Vayssière J.L. Mitochondria and apoptosis. Eur. J. Biochem. 1998, 252:1-15.
33. Mori M., Aihara M., Kume K., Hamanoue M., Kohsaka S., Shimizu T. Predominant expression of platelet-activating factor receptor in the rat brain microglia. J. Neurosci. 1996, 16:3590-3600.
34. Mori M., Aihara M., Kume K., Hamanoue M., Kohsaka S., Shimizu T. Localization of platelet-activating factor receptor in the rat brain. Adv. Exp. Med. Biol. 1997, 407:357-363.
35. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
36. Oberhammer F.A., Pavelka M., Sharma S., Tiefenbacher R., Purchio A.F., Bursch W., Schulte-Hermann R. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:5408-5412.
37. Ott M., Gogvadze V., Orrenius S., Zhivotovsky B. Mitochondria, oxidative stress and cell death. Apoptosis 2007, 12:913-922.
38. +-induced dopaminergic neuronal cell death: its potential role as a survival determinant. Biochem. Biophys. Res. Commun. 2004, 322:727-733.
39. Parker M.A., Bazan H.E., Marcheselli V., Rodriguez de Turco E.B., Bazan N.G. Platelet-activating factor induces permeability transition and cytochrome c release in isolated brain mitochondria. J. Neurosci. Res. 2002, 69:39-50.
40. Prescott S.M., Zimmerman G.A., Stafforini D.M., McIntyre T.M. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 2000, 69:419-445.
41. Rong P., Bennie A.M., Epa W.R., Barrett G.L. Nerve growth factor determines survival and death of PC12 cells by regulation of the bcl-x, bax, and caspase-3 genes. J. Neurochem. 1999, 72:2294-2300.
42. Ryan S.D., Harris C.S., Mo F., Lee H., Hou S.T., Bazan N.G., Haddad P.S., Arnason J.T., Bennett S.A. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid. J. Neurochem. 2007, 103:88-97.
43. Sarkar F.H., Li Y., Wang Z., Kong D. NF-κB signaling pathway and its therapeutic implications in human diseases. Int. Rev. Immunol. 2008, 27:293-319.
44. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 1989, 17:6419.
45. Seo K.H., Ko H.M., Kim H.A., Choi J.H., Park J.S., Kim K.J., Lee H.K., Im S.Y. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-κB activation. Cancer Res. 2006, 66:4681-4686.
46. Southall M.D., Isenberg J.S., Nakshatri H., Yi Q., Pei Y., Spandau D.F., Travers J.B. The platelet-activating factor receptor protects epidermal cells from tumor necrosis factor (TNF) α and TNF-related apoptosis-inducing ligand-induced apoptosis through an NF-κB-dependent process. J. Biol. Chem. 2001, 276:45548-45554.
47. Storch A., Ludolph A.C., Schwarz J. Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J. Neural Transm. 2004, 111:1267-1286.
48. Tatton W.G., Chalmers-Redman R.M.E., Ju W.J.H., Mammen M., Carlile G.W., Pong A.W., Tatton N.A. Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J. Pharmacol. Exp. Ther. 2002, 301:753-764.
49. Tiberghien C., Laurent L., Junier M.P., Dray F. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain. J. Lipid Mediat. 1991, 3:249-266.
50. van Klaveren R.J., Hoet P.H.M., Pype J.L., Demedts M., Nemery B. Increase in γ-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic. Biol. Med. 1997, 22:525-534.
51. Wu Y., Shang Y., Sun S.G., Liu R.G., Yang W.Q. Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells. Neurosci. Bull. 2007, 23:156-164.
52. Xu Y., Tao Y.X. Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. Neuroreport 2004, 15:263-266.
53. Yeo E.J., Ryu J.H., Chun Y.S., Cho Y.S., Jang I.J., Cho H., Kim J., Kim M.S., Park J.W. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases. Cancer Res. 2006, 66:6345-6352.